Lv31
260 积分 2023-12-08 加入
The high-grade B-cell lymphomas: Double hit and more
1小时前
已完结
Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures
27天前
已完结
Clinical and economic studies of pharmacotherapy for multiple myeloma: literature review data
27天前
已完结
Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures
1个月前
已关闭
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial
2个月前
已关闭
Daratumumab for maintenance in myeloma
2个月前
已关闭
Daratumumab for maintenance in myeloma
2个月前
已关闭
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial
2个月前
已完结
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial
2个月前
已关闭
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
5个月前
已完结
皖公网安备34019202002308
